‘Off-the-shelf’ allogeneic CAR T cells: development and challenges

Stéphane Depil; Philippe Duchâteau; Stephan A. Grupp; G J Mufti; Laurent Poirot

doi:10.1038/s41573-019-0051-2

Keywords

Chimeric antigen receptorImmune systemImmunologyImmunotherapyT cellAntigenGraft-versus-host diseaseMedicineCell therapyDiseaseCancer researchBiologyStem cellInternal medicineCell biology

Affiliated Institutions

Related Publications

CAR T cell immunotherapy for human cancer

Carl H. June , Roddy S. O’Connor , Omkar U. Kawalekar +2 more

Adoptive T cell transfer (ACT) is a new area of transfusion medicine involving the infusion of lymphocytes to mediate antitumor, antiviral, or anti-inflammatory effects. The fie...

2018 Science 2861 citations

CAR-T cell therapy: current limitations and potential strategies

Robert C. Sterner , Rosalie M. Sterner

Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary new pillar in cancer treatment. Although treatment with CAR-T cells has produced remarkable clinical responses ...

2021 Blood Cancer Journal 2373 citations

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja , Deepu Madduri , Saad Z. Usmani +33 more

CARTITUDE-1 aimed to assess the safety and clinical activity of ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor T-cell therapy with two B-cell maturation anti...

2021 The Lancet 1466 citations

Chimeric Antigen Receptor Therapy

Carl H. June , Michel Sadelain

Interview with Dr. Carl June on chimeric antigen receptor therapy. (09:04)Download This review addresses T-cell engineering and synthetic immunity, with a focus on producing dur...

2018 New England Journal of Medicine 2080 citations

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Stephan A. Grupp , Michael Kalos , David M. Barrett +10 more

Chimeric antigen receptor-modified T cells with specificity for CD19 have shown promise in the treatment of chronic lymphocytic leukemia (CLL). It remains to be established whet...

2013 New England Journal of Medicine 3403 citations

Publication Info

Year: 2020
Type: review
Volume: 19
Issue: 3
Pages: 185-199
Citations: 1056
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

‘Off-the-shelf’ allogeneic CAR T cells: development and challenges

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1056

OpenAlex

Cite This

APA Style

                            
                                
                                    Stéphane Depil, 
                                
                                    Philippe Duchâteau, 
                                
                                    Stephan A. Grupp
                                
                                et al.
                            
                            (2020). 
                            ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges. 
                            Nature Reviews Drug Discovery
                            , 19
                            (3)
                            , 185-199.
                            https://doi.org/10.1038/s41573-019-0051-2
                        

Identifiers

DOI: 10.1038/s41573-019-0051-2